9647.Se
The company operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services.
Business. The company operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services.
The company maintains a strong capital structure with no debt, as evidenced by a debt-to-equity ratio of 0.0. This indicates a conservative approach to financing, with total equity of 31,523,540.0. The company's liquidity position is not directly assessable due to the absence of balance-sheet inputs and no going-concern language in the source documents.
Profitability is robust, with a return on equity of 0.1897. This performance is in line with the industry's preferred metrics, which emphasize efficient use of equity capital to generate returns. The company's net income of 5,981,470.0 reflects its ability to convert revenue into profit, with a revenue of 85,197,760.0.
The company's revenue is not segmented by geographic regions or business lines in the available data, making it difficult to assess the concentration of revenue across different markets or product lines. However, the absence of detailed segment data suggests a potentially diversified revenue base or a lack of public disclosure on this aspect.
The company's growth trajectory is not explicitly outlined in the available data, but the current revenue of 85,197,760.0 provides a baseline for future performance. The outlook for the current fiscal year and the next fiscal year is not specified, but the company's profitability and capital structure suggest a stable financial position.
The risk assessment indicates a low potential for dilution, with no significant dilution risk identified. The company's conservative capital structure, with no debt, and the absence of dilution risk factors suggest a stable equity position. However, the liquidity risk could not be assessed due to the lack of balance-sheet inputs and no going-concern language in the source documents.
Recent events and filings do not provide specific details on the company's operations or strategic initiatives. The absence of detailed information on recent events suggests a need for further investigation into the company's strategic direction and operational performance.
- The company has a strong return on equity of 0.1897, indicating efficient use of equity capital.
- The company maintains a conservative capital structure with no debt, as shown by a debt-to-equity ratio of 0.0.
- The company's liquidity risk could not be assessed due to the lack of balance-sheet inputs and no going-concern language in the source documents.
- The company's revenue is not segmented by geographic regions or business lines, making it difficult to assess the concentration of revenue across different markets or product lines.
- The company has a low potential for dilution, with no significant dilution risk identified.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Return On Equitynet_income / total_equity
- 9647.SE Market data — financials · 2026-05-27